3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Motor Activity
234
Breast Neoplasms
132
Neoplasms
97
Prostatic Neoplasms
34
Fatigue
34
Obesity
24
Lung Neoplasms
23
Colorectal Neoplasms
22
Polycystic Ovary Syndrome
17
Ovarian Neoplasms
13
Colonic Neoplasms
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Pancreatic Neoplasms
11
Lymphoma
11
Carcinoma, Non-Small-Cell Lung
11
Weight Loss
10
Rectal Neoplasms
10
Multiple Myeloma
10
Lymphedema
10
Hematologic Neoplasms
10
Head and Neck Neoplasms
10
Leukemia
9
Cardiotoxicity
9
Insulin Resistance
8
Brain Neoplasms
8
Stomach Neoplasms
7
Peripheral Nervous System Diseases
7
Overweight
6
Esophageal Neoplasms
6
Cognitive Dysfunction
6
Interventions
Cyclophosphamide
87
fludarabine phosphate
86
Peripheral Blood Stem Cell Transplantation
70
Mycophenolic Acid
58
Tacrolimus
57
Busulfan
57
Whole-Body Irradiation
55
Antilymphocyte Serum
47
Cyclosporine
46
fludarabine
39
Methotrexate
38
Filgrastim
38
Melphalan
32
ruxolitinib
30
Cytarabine
30
Radiotherapy
27
Azacitidine
23
Etoposide
21
Methylprednisolone
20
Cord Blood Stem Cell Transplantation
18
Specimen Handling
15
Sirolimus
15
Granulocyte Colony-Stimulating Factor
15
Decitabine
15
Cyclosporins
14
Biopsy
14
Alemtuzumab
14
thymoglobulin
13
venetoclax
11
sargramostim
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Myeloproliferative Disorders
×
Exercise
×
Clear all
NCT07384039
2026-02-05
MPN-Exercise
Hannover Medical School
Phase NA
Not yet recruiting
80 enrolled